Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ecancer-Oncosalud Symposium of Molecular Clinical Oncology 2019 /
Symptomatic control in palliative medicine

18th - 19th Jul 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 07.08.19
Views: 1036

Dr Benjamín Cavenago Salazar - Government of Callao, Callao, Peru

Dr Benjamín Cavenago Salazar speaks to ecancer at the 2019 ecancer-Oncosalud Symposium of Molecular Clinical Oncology in Peru about the importance of symptomatic control, especially in the palliative setting.

He describes there is a lack of understanding of palliative care, as there is a major focus on curative care. He emphasises that attention should be given to this type of care, as older patients are now increasingly affected by oncological diseases - in which curative options remain limited.

In terms of the future, Dr Salazar remains optimistic and believes we are on the right path in addressing this epidemiological transition.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation